MIST·59935V107·US·equity·Healthcare - Biotechnology-13D/G
MIST (MILESTONE PHARMACEUTICALS IN) is held by 45 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($7.5M), TWO SIGMA INVESTMENTS, LP ($2.8M), GOLDMAN SACHS GROUP INC ($2.4M). Net institutional sentiment: Mixed.
See how MIST's score breaks down across 4 SEC sources
Showing 1-20 of 53
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer